Literature DB >> 32346090

Does asthma make COVID-19 worse?

Samarth Hegde1.   

Abstract

Entities:  

Year:  2020        PMID： 32346090      PMCID： PMC7186942          DOI： 10.1038/s41577-020-0324-3

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN： 1474-1733            Impact factor:   108.555


× No keyword cloud information.
  1 in total

1.  Type 2 and interferon inflammation regulate SARS-CoV-2 entry factor expression in the airway epithelium.

Authors:  Satria P Sajuthi; Peter DeFord; Yingchun Li; Nathan D Jackson; Michael T Montgomery; Jamie L Everman; Cydney L Rios; Elmar Pruesse; James D Nolin; Elizabeth G Plender; Michael E Wechsler; Angel C Y Mak; Celeste Eng; Sandra Salazar; Vivian Medina; Eric M Wohlford; Scott Huntsman; Deborah A Nickerson; Soren Germer; Michael C Zody; Gonçalo Abecasis; Hyun Min Kang; Kenneth M Rice; Rajesh Kumar; Sam Oh; Jose Rodriguez-Santana; Esteban G Burchard; Max A Seibold
Journal:  Nat Commun       Date:  2020-10-12       Impact factor: 14.919
  1 in total
  6 in total

1.  Sustained decrease in pediatric asthma emergency visits during the first year of the COVID-19 pandemic.

Authors:  Samantha Arsenault; Jacob Hoofman; Pavadee Poowuttikul; Elizabeth Secord
Journal:  Allergy Asthma Proc       Date:  2021-09-01       Impact factor: 2.587

2.  Clinical characteristics in 545 patients with severe asthma on biological treatment during the COVID-19 outbreak.

Authors:  Manuel Jorge Rial; Marcela Valverde; Victoria Del Pozo; Francisco Javier González-Barcala; Carlos Martínez-Rivera; Xavier Muñoz; José María Olaguibel; Vicente Plaza; Elena Curto; Santiago Quirce; Pilar Barranco; Javier Domínguez-Ortega; Joaquin Mullol; César Picado; Antonio Valero; Irina Bobolea; Ebymar Arismendi; Paula Ribó; Joaquín Sastre
Journal:  J Allergy Clin Immunol Pract       Date:  2020-10-09

3.  Asthma and COVID-19: a systematic review.

Authors:  Natália F Mendes; Carlos P Jara; Eli Mansour; Eliana P Araújo; Licio A Velloso
Journal:  Allergy Asthma Clin Immunol       Date:  2021-01-06       Impact factor: 3.406

4.  Decision and feature level fusion of deep features extracted from public COVID-19 data-sets.

Authors:  Hamza Osman Ilhan; Gorkem Serbes; Nizamettin Aydin
Journal:  Appl Intell (Dordr)       Date:  2021-10-30       Impact factor: 5.019

Review 5.  Risk Assessment for Patients with Chronic Respiratory Conditions in the Context of the SARS-CoV-2 Pandemic Statement of the German Respiratory Society with the Support of the German Association of Chest Physicians.

Authors:  Marek Lommatzsch; Klaus F Rabe; Christian Taube; Marcus Joest; Michael Kreuter; Hubert Wirtz; Torsten Gerriet Blum; Martin Kolditz; Hilte Geerdes-Fenge; Ralf Otto-Knapp; Brit Häcker; Tom Schaberg; Felix C Ringshausen; Claus F Vogelmeier; Niels Reinmuth; Martin Reck; Jens Gottlieb; Stavros Konstantinides; Joachim Meyer; Heinrich Worth; Wolfram Windisch; Tobias Welte; Torsten Bauer
Journal:  Respiration       Date:  2022-01-21       Impact factor: 3.966

6.  Characteristics, risk factors and outcomes among the first consecutive 1096 patients diagnosed with COVID-19 in Kuwait.

Authors:  Sulaiman Almazeedi; Sarah Al-Youha; Mohammad H Jamal; Mohannad Al-Haddad; Ali Al-Muhaini; Fahad Al-Ghimlas; Salman Al-Sabah
Journal:  EClinicalMedicine       Date:  2020-07-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.